Danish Pharma Stock News

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

When close to half the companies in Denmark have price-to-earnings ratios (or "P/E's") below 14x, you may consider...

For many, the main point of investing is to generate higher returns than the overall market. But every investor is...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

The Bang & Olufsen A/S ( CPH:BO ) share price has done very well over the last month, posting an excellent gain of 33...

DFDS A/S ( CPH:DFDS ), might not be a large cap stock, but it saw significant share price movement during recent months...

It looks like Per Aarsleff Holding A/S ( CPH:PAAL B ) is about to go ex-dividend in the next 3 days. The ex-dividend...

Key Insights Institutions' substantial holdings in Zealand Pharma implies that they have significant influence over the...

The OrderYOYO A/S ( CPH:YOYO ) share price has done very well over the last month, posting an excellent gain of 27...

Coloplast A/S' ( CPH:COLO B ) price-to-earnings (or "P/E") ratio of 36.1x might make it look like a strong sell right...

As global markets continue to react positively to recent political developments and economic indicators, major indices like the S&P 500 have reached new record highs, driven by optimism around trade policies and AI investments. Amidst this buoyant market environment, identifying stocks that are potentially undervalued can be a strategic move for investors looking to capitalize on discrepancies between market price and intrinsic value.

When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Key Insights Using the 2 Stage Free Cash Flow to Equity, FLSmidth fair value estimate is kr.671 Current share price of...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Embla Medical hf fair value estimate is kr.39.19 With kr.34.00...

Novo Nordisk (CPH:NOVO B) has had a rough three months with its share price down 21%. But if you pay close attention...

Tryg ( CPH:TRYG ) Full Year 2024 Results Key Financial Results Revenue: kr.41.1b (up 2.4% from FY 2023). Net income...

Statistically speaking, long term investing is a profitable endeavour. But that doesn't mean long term investors can...

Taking the occasional loss comes part and parcel with investing on the stock market. And there's no doubt that Vestas...

Insiders were net sellers of NKT A/S' ( CPH:NKT ) stock during the past year. That is, insiders sold more stock than...

Alm. Brand ( CPH:ALMB ) Full Year 2024 Results Key Financial Results Revenue: kr.11.5b (down 24% from FY 2023). Net...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...